Whalegun
Home

Regeneron Pharmaceuticals REGN spent $460K on lobbying in Q1 2023 · Medicare, Copyright and 1 more issue

Trade details

Type
Lobbying report
Amount
$460,000
Quarter
Q1 2023
Stock
Regeneron Pharmaceuticals REGN
Client
Regeneron Pharmaceuticals
Reported
23/04/20

Up 43.8% from last quarter

What else happened in Regeneron Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/03/01~23/04/30

Regeneron Pharmaceuticals's other lobbying reports

Regeneron Pharmaceuticals REGN spent $460K on lobbying in Q1 2023 · Medicare, Copyright and 1 more issue | Whalegun